ICU Medical Inc (ICUI) shareholders
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3034% above fair value
$179.27+1.97 (+1.11%)
Close on Nov 13, 2026Market cap $4.48BP/E 74.4Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
26M of 25M shares
Institutional holders
288
47 new, 30 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 19 sales
Net sold $8.27M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 3,649,469 | – | 13G (passive) amendment | Sep 30, 2024 |
| JANUS HENDERSON GROUP Ltd. | 2,781,621 | 11.10% | 13G (passive) amendment | Jun 30, 2026 |
| Janus Henderson Group PLC Joint filing with Janus Henderson Enterprise Fund (5.00%) | 2,470,146 | 10.00% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Portfolio Management | 1,455,765 | 5.82% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 1,298,459 | 5.19% | 13G (passive) | Mar 31, 2026 |
| Fuller & Thaler Asset Management, Inc. | 1,298,127 | 5.19% | 13G (passive) amendment | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ICUI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,753,409 | 15.01% | $550.25M | +145,087 | 0.01% |
| Jupiter Topco LLC | 2,781,620 | 11.12% | $407.79M | New | 0.17% |
| Vanguard Portfolio Management LLC | 1,470,583 | 5.88% | $215.59M | +32,907 | 0.01% |
| Fuller & Thaler Asset Management, Inc. | 1,298,127 | 5.19% | $190.31M | +77,588 | 0.52% |
| Vanguard Capital Management LLC | 1,123,237 | 4.49% | $164.67M | +11,362 | 0.00% |
| Dimensional Fund Advisors LP | 1,053,476 | 4.21% | $154.44M | +69,674 | 0.03% |
| State Street Corp | 1,024,369 | 4.10% | $150.18M | +56,316 | 0.00% |
| Schroder Investment Management Group | 739,138 | 2.96% | $109.34M | +37,858 | 0.08% |
| Ameriprise Financial Inc | 689,573 | 2.76% | $101.09M | +83,845 | 0.02% |
| Geode Capital Management, LLC | 660,423 | 2.64% | $96.84M | +49,204 | 0.01% |
| River Road Asset Management, LLC | 626,290 | 2.50% | $91.81M | −20,140 | 1.02% |
| Citadel Advisors LLC | 536,225 | 2.14% | $78.61M | +202,889 | 0.01% |
| Neuberger Berman Group LLC | 451,279 | 1.80% | $66.16M | +4,860 | 0.04% |
| JPMorgan Chase & Co | 440,468 | 1.76% | $65.31M | −27,349 | 0.00% |
| Goldman Sachs Group Inc | 417,342 | 1.67% | $61.18M | +94,651 | 0.01% |
| Thrivent Financial for Lutherans | 381,139 | 1.52% | $55.88M | −52,360 | 0.09% |
| Morgan Stanley | 372,583 | 1.49% | $54.62M | −154,259 | 0.00% |
| Bank Of America Corp /De/ | 368,754 | 1.47% | $54.06M | +37,015 | 0.00% |
| Toronto Dominion Bank | 358,023 | 1.43% | $52.49M | +149,091 | 0.06% |
| Charles Schwab Investment Management Inc | 331,052 | 1.32% | $48.53M | +8,573 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 288 | 26M | 100.0% | 47 / 120 | 83 / 30 | 5M | 1M |
| Q1 2026 | 276 | 25M | 100.0% | 37 / 92 | 102 / 47 | 4M | 3M |
| Q4 2025 | 292 | 27M | 100.0% | 59 / 97 | 97 / 30 | 4M | 4M |
| Q3 2025 | 270 | 26M | 100.0% | 49 / 89 | 95 / 48 | 3M | 2M |
| Q2 2025 | 271 | 25M | 100.0% | 34 / 124 | 80 / 42 | 2M | 1M |
| Q1 2025 | 281 | 25M | 98.0% | 39 / 86 | 106 / 38 | 2M | 2M |
| Q4 2024 | 286 | 24M | 96.8% | 41 / 103 | 96 / 40 | 2M | 3M |
| Q3 2024 | 289 | 25M | 100.0% | 57 / 107 | 77 / 21 | 6M | 2M |
| Q2 2024 | 255 | 25M | 98.2% | 43 / 99 | 75 / 38 | 3M | 3M |
| Q1 2024 | 252 | 25M | 99.0% | 38 / 102 | 71 / 27 | 3M | 2M |
| Q4 2023 | 241 | 23M | 91.7% | 56 / 90 | 62 / 31 | 6M | 5M |
| Q3 2023 | 220 | 22M | 89.2% | 30 / 72 | 80 / 40 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
331 funds held ICUI in Q2 2026, 42% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ICUI | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 1,505,864 | 6.02% | $220.76M | 0.20% | Jun 30, 2026 |
| Janus Henderson Enterprise Fund | 1,230,753 | 4.92% | $180.43M | 0.81% | Jun 30, 2026 |
| Undiscovered Managers Behavioral Value Fund | 1,054,324 | 4.22% | $154.56M | 1.71% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 791,929 | 3.17% | $116.10M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 634,293 | 2.54% | $92.99M | 0.11% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 573,522 | 2.29% | $84.08M | 0.04% | Jun 30, 2026 |
| Columbia Small Cap Growth Fund | 448,705 | 1.79% | $60.75M | 1.65% | May 31, 2026 |
| Janus Henderson Triton Fund | 374,990 | 1.50% | $54.97M | 0.93% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 363,100 | 1.45% | $53.23M | 0.08% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 286,086 | 1.14% | $41.94M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 270,008 | 1.08% | $45.50M | 0.13% | Jul 31, 2026 |
| Thrivent Small Cap Stock Fund | 257,476 | 1.03% | $43.39M | 1.49% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 231,353 | 0.93% | $33.92M | 0.23% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 230,029 | 0.92% | $33.72M | 0.20% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 227,281 | 0.91% | $38.30M | 0.20% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Vivek Jain | Chairman and CEO, Director | 276,993 | 1.11% | Mar 16, 2026 |
| Virginia Ruth Sanzone | VP, General Counsel | 16,020 | 0.06% | Sep 3, 2026 |
| Brian Michael Bonnell | Chief Financial Officer | 56,062 | 0.22% | Sep 1, 2026 |
| Daniel Woolson | VP, GM-Infusion Capital | 17,062 | 0.07% | Aug 13, 2026 |
| Ben Sousa | Chief Information Officer | 3,076 | 0.01% | Aug 12, 2026 |
| Christian B. Voigtlander | Chief Operating Officer | 37,377 | 0.15% | Aug 11, 2026 |
| Elisha W. Finney | Director | 4,871 | 0.02% | Nov 13, 2026 |
| David F. Hoffmeister | Director | 6,004 | 0.02% | May 13, 2026 |
| David C. Greenberg | Director | 9,714 | 0.04% | May 13, 2026 |
| Donald Abbey | Director | 6,004 | 0.02% | May 13, 2026 |
| Laurie Hernandez | Director | 4,862 | 0.02% | May 13, 2026 |
| Kolleen T. Kennedy | Director | 4,539 | 0.02% | May 13, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Elisha W. Finney Director | Nov 13, 2026 | Sale | −1,700 | $179.00 | $304.30K | 4,871 |
| Elisha W. Finney Director | Nov 13, 2026 | Option exercise | +1,700 | $158.20 | $268.94K | 6,571 |
| Elisha W. Finney Director | Nov 12, 2026 | Sale | −65 | $179.00 | $11.64K | 4,871 |
| Elisha W. Finney Director | Nov 12, 2026 | Option exercise | +65 | $158.20 | $10.28K | 4,936 |
| Virginia Ruth Sanzone VP, General Counsel | Sep 3, 2026 | Sale(10b5-1 plan) | −1,238 | $168.44 | $208.53K | 16,020 |
| Virginia Ruth Sanzone VP, General Counsel | Sep 3, 2026 | Sale(10b5-1 plan) | −724 | $169.53 | $122.74K | 15,296 |
| Virginia Ruth Sanzone VP, General Counsel | Sep 3, 2026 | Sale(10b5-1 plan) | −692 | $171.52 | $118.69K | 14,604 |
| Virginia Ruth Sanzone VP, General Counsel | Sep 3, 2026 | Sale(10b5-1 plan) | −2,202 | $167.67 | $369.21K | 17,258 |
| Brian Michael Bonnell Chief Financial Officer | Sep 1, 2026 | Sale(10b5-1 plan) | −6,381 | $175.00 | $1.12M | 56,062 |
| Brian Michael Bonnell Chief Financial Officer | Aug 31, 2026 | Sale(10b5-1 plan) | −4,568 | $173.44 | $792.27K | 63,556 |
| Brian Michael Bonnell Chief Financial Officer | Aug 31, 2026 | Sale(10b5-1 plan) | −1,712 | $171.05 | $292.84K | 70,038 |
| Brian Michael Bonnell Chief Financial Officer | Aug 31, 2026 | Sale(10b5-1 plan) | −1,914 | $172.12 | $329.44K | 68,124 |
| Brian Michael Bonnell Chief Financial Officer | Aug 31, 2026 | Sale(10b5-1 plan) | −1,113 | $173.91 | $193.56K | 62,443 |
| Daniel Woolson VP, GM-Infusion Capital | Aug 13, 2026 | Sale | −5,417 | $181.33 | $982.26K | 17,062 |
| Ben Sousa Chief Information Officer | Aug 12, 2026 | Sale | −2,250 | $178.32 | $401.22K | 3,076 |
| Christian B. Voigtlander Chief Operating Officer | Aug 11, 2026 | Sale | −8,929 | $182.93 | $1.63M | 37,377 |
| Elisha W. Finney Director | Aug 11, 2026 | Sale | −378 | $182.48 | $68.98K | 4,871 |
| Daniel Woolson President | May 22, 2026 | Sale | −2,123 | $132.21 | $280.68K | 22,479 |
| Virginia Ruth Sanzone VP, General Counsel | May 14, 2026 | Sale | −2,447 | $124.08 | $303.62K | 19,460 |
| Donald Abbey Director | May 13, 2026 | Option exercise | +1,254 | – | – | 6,004 |
| Elisha W. Finney Director | May 13, 2026 | Option exercise | +1,254 | – | – | 5,249 |
| David F. Hoffmeister Director | May 13, 2026 | Option exercise | +1,254 | – | – | 6,004 |
| Laurie Hernandez Director | May 13, 2026 | Option exercise | +1,254 | – | – | 4,862 |
| Kolleen T. Kennedy Director | May 13, 2026 | Option exercise | +1,254 | – | – | 4,539 |
| David C. Greenberg Director | May 13, 2026 | Option exercise | +1,254 | – | – | 9,214 |
| David C. Greenberg Director | May 12, 2026 | Sale | −2,424 | $122.91 | $297.93K | 7,960 |
| David C. Greenberg Director | May 12, 2026 | Option exercise | +2,424 | $101.06 | $244.97K | 10,384 |
| Donald Abbey Director | Mar 25, 2026 | Other | −704 | – | – | 4,046 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 15, 2026 | Option exercise | +5,700 | – | – | 24,330 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 15, 2026 | Tax withholding | −3,150 | $125.85 | $396.43K | 21,180 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 15, 2026 | Option exercise | +1,624 | – | – | 22,804 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 15, 2026 | Tax withholding | −897 | $125.85 | $112.89K | 21,907 |
| Vivek Jain Chairman and CEO, Director | Mar 15, 2026 | Tax withholding | −9,452 | $125.85 | $1.19M | 124,654 |
| Vivek Jain Chairman and CEO, Director | Mar 15, 2026 | Option exercise | +4,872 | – | – | 129,526 |
| Vivek Jain Chairman and CEO, Director | Mar 15, 2026 | Tax withholding | −2,693 | $125.85 | $338.91K | 126,833 |
| Vivek Jain Chairman and CEO, Director | Mar 15, 2026 | Option exercise | +17,100 | – | – | 134,106 |
| Brian Michael Bonnell Chief Financial Officer | Mar 15, 2026 | Tax withholding | −1,795 | $125.85 | $225.90K | 71,750 |
| Brian Michael Bonnell Chief Financial Officer | Mar 15, 2026 | Option exercise | +11,400 | – | – | 76,097 |
| Brian Michael Bonnell Chief Financial Officer | Mar 15, 2026 | Tax withholding | −5,800 | $125.85 | $729.93K | 70,297 |
| Brian Michael Bonnell Chief Financial Officer | Mar 15, 2026 | Option exercise | +3,248 | – | – | 73,545 |
| Christian B. Voigtlander Chief Operating Officer | Mar 15, 2026 | Option exercise | +11,400 | – | – | 51,154 |
| Christian B. Voigtlander Chief Operating Officer | Mar 15, 2026 | Option exercise | +3,248 | – | – | 48,101 |
| Christian B. Voigtlander Chief Operating Officer | Mar 15, 2026 | Tax withholding | −6,301 | $125.85 | $792.98K | 44,853 |
| Christian B. Voigtlander Chief Operating Officer | Mar 15, 2026 | Tax withholding | −1,795 | $125.85 | $225.90K | 46,306 |
| Ben Sousa Chief Information Officer | Mar 15, 2026 | Tax withholding | −718 | $125.85 | $90.36K | 5,326 |
| Ben Sousa Chief Information Officer | Mar 15, 2026 | Option exercise | +1,300 | – | – | 6,044 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 15, 2026 | Tax withholding | −1,295 | $125.85 | $162.98K | 24,602 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 15, 2026 | Option exercise | +2,924 | – | – | 25,897 |
| Brian Michael Bonnell Chief Financial Officer | Mar 8, 2026 | Option exercise | +71,757 | – | – | 104,364 |
| Brian Michael Bonnell Chief Financial Officer | Mar 8, 2026 | Tax withholding | −39,667 | $132.00 | $5.24M | 64,697 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 8, 2026 | Option exercise | +23,917 | – | – | 30,424 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 8, 2026 | Tax withholding | −13,221 | $132.00 | $1.75M | 17,203 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 8, 2026 | Tax withholding | −1,762 | $132.00 | $232.58K | 18,630 |
| Virginia Ruth Sanzone VP, General Counsel | Mar 8, 2026 | Option exercise | +3,189 | – | – | 20,392 |
| Ben Sousa Chief Information Officer | Mar 8, 2026 | Tax withholding | −529 | $132.00 | $69.83K | 4,744 |
| Ben Sousa Chief Information Officer | Mar 8, 2026 | Option exercise | +957 | – | – | 5,273 |
| Ben Sousa Chief Information Officer | Mar 8, 2026 | Tax withholding | −3,967 | $132.00 | $523.64K | 4,316 |
| Ben Sousa Chief Information Officer | Mar 8, 2026 | Option exercise | +7,177 | – | – | 8,283 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 8, 2026 | Tax withholding | −6,877 | $132.00 | $907.76K | 21,450 |
| Daniel Woolson VP, GM-Infusion Capital | Mar 8, 2026 | Option exercise | +16,147 | – | – | 28,327 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
6.81%
2M shares short
Days to cover
8.0
At 0M shares a day
Change since last report
-2.4%
From 2M shares
Short volume, 20 days
65.9%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of ICU Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 6,970 shares on Aug 18, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Virginia Ruth Sanzone Officer | Sep 3, 2026 | 4,856 | $819.15K | Sep 3, 2026 | Performance and Restricted Stock |
| Brian Michael Bonnell Officer | Sep 1, 2026 | 6,381 | $1.12M | Sep 1, 2026 | Restricted Stock |
| Brian Michael Bonnell Officer | Aug 31, 2026 | 9,307 | $1.61M | Aug 31, 2026 | Performance Shares and Restricted Stock |
| Daniel Woolson Officer | Aug 13, 2026 | 5,417 | $982.26K | Aug 13, 2026 | Performance Stock Units |
| Benjamin Sousa Officer | Aug 12, 2026 | 2,250 | $401.21K | Aug 12, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Elisha W. Finney Director | Aug 11, 2026 | 378 | $68.98K | Aug 11, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Christian B. Voigtlander Officer | Aug 11, 2026 | 8,929 | $1.63M | Aug 11, 2026 | Previously Exercised Options |
| Daniel Woolson Officer | May 22, 2026 | 2,123 | $280.68K | May 22, 2026 | Performance Stock Units |
| Virginia Ruth Sanzone Officer | May 14, 2026 | 2,447 | $303.62K | May 14, 2026 | Performance Stock Units |
| David C. Greenberg Director | May 12, 2026 | 2,424 | $297.93K | May 12, 2026 | Exercise of options under a registered plan |
| Daniel Woolson Officer | Nov 25, 2025 | 2,897 | $441.36K | Nov 25, 2025 | Performance Shares |
| Elisha W. Finney Director | Nov 12, 2025 | 1,285 | $180.44K | Nov 11, 2025 | Stock Option Exercise |
| Virginia Ruth Sanzone Officer | Nov 12, 2025 | 930 | $132.38K | Nov 11, 2025 | Restricted Stock |
| Virginia Ruth Sanzone Officer | May 30, 2025 | 700 | $93.54K | May 30, 2025 | Performance Shares |
| Elisha W. Finney Director | May 19, 2025 | 600 | $83.35K | May 19, 2025 | RESTRICTED STOCK |
See a number that looks wrong?